VITAMIN D DEFICIENCY AND CENTRAL PRECOCIOUS PUBERTY (CPP) IN CHILDREN WITH AUTISM SPECTRUM DISORDER (ASD) - A CASE SERIES
DOI:
https://doi.org/10.15605/jafes.037.S2.77Keywords:
central precocious puberty, autismspectrum disorder, Vitamin D deficiencyAbstract
INTRODUCTION
More children with Autism Spectrum Disorder (ASD) are being recognised. Management of ASD remains challenging. We report 2 children with ASD manifesting with Vitamin D deficiency and 5 children with ASD and central precocious puberty (CPP). DSM-5 classification is used to describe the autism severity.
CASES
Two patients presented with symptomatic hypocalcaemia. Patient A (13 years old; severe ASD level 3) had carpopedal spasms and Patient B (3 years old; ASD level 3) had rickets. Both had restricted diet variations and were stunted (height SDS -2.07 and -2.9 respectively). Patient A had serum calcium of 1.61mmol/L, ALP of 799 U/L, iPTH of 25.2 pmol/L, and Vitamin D of 18 nmol/L. Patient B had serum calcium of 1.66 mmol/L, ALP of 2333 U/L, iPTH of 42.2 pmol/L, and Vitamin D of 11 nmol/L. Both required intravenous calcium gluconate, oral calcium carbonate, cholecalciferol, and calcitriol. Both their serum calcium levels normalized with treatment. Five patients were referred for CPP. Patients C (8 years old; ASD level 1) and D (7.2 years old; ASD level 3) were siblings who presented with isolated thelarche. Patient E (5.6 years old; ASD level 1) had thelarche and menarche. Patient F (7 years old; ASD level 1) presented with tall stature and thelarche. Patient G (8.5 years old; ASD level 3) presented with advanced puberty. Three of the five children with CPP had abnormal psychological traits (genitalia rubbing). At presentation, breast staging varies between Tanner 2-4, and pubic hair at Tanner 2-3. The mean basal LH level was 0.8 ± 0.8IU/L, mean FSH was 5.8 ± 2.87 IU/L, and mean estradiol was 179 ± 128.2 pmol/L. Bone ages were advanced ranging from 0.6 to 3 years and ultrasonography of the pelvis revealed pubertal uterine development. Three required LHRH tests to confirm the diagnosis. All were treated with GnRH agonists. Only 1 patient completed treatment.
CONCLUSION
Early recognition and therapy may benefit these children.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ee Yun Yau, Nurshaida Samingan, Muhammad Yazid Jalaluddin, Azriyanti Anuar Zaini

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.





